November 15, 2022 10:54 AM EST

ElevateBio and Affini-T partner on KRAS therapies; Casma raises $46M to drug the cell’s garbage disposal system

Lei Lei Wu

News Reporter

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

Altos Labs buys anti-aging startup Dorian Therapeutics

Genentech expands deal with molecular glue biotech Orionis for $105M upfront

How PureTech’s lung fibrosis drug stacks up against the competition

Cocaine vaccine, a longshot attempt to quell cravings, yields mixed data in small study

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?